Oaktree Specialty Lending trades attractively cheap with a solid earnings beat streak, but declining revenue and a negative free-cash-flow earnings-quality flag raise value-trap concerns after the stock already reached its analyst target.
Thesis pillars
- Attractive Valuation Earnings Beat→Stable
- Negative Fcf Earnings Quality Flag→Stable
- Revenue Decline Value Trap Signal→Stable
- +1 more pillar — see the Why tab for full reasoning
Oaktree Specialty Lending Corpo (OCSL) Stock Analysis
Inst Constrain edge
Financial Services · Asset Management
Hold if already holding. Not a fresh buy at $11.60, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Leverage penalty (D/E 1.0): -0.5.
Oaktree Specialty Lending Corporation is a business development company. The fund specializing in investments in middle market, bridge financing, first and second lien debt financing, unsecured and mezzanine loan, mezzanine debt, senior and junior secured debt, expansions,... Read more
Hold if already holding. Not a fresh buy at $11.60, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Leverage penalty (D/E 1.0): -0.5. Chart setup: No clear chart pattern; technical signals are mixed. Maintain position. Not compelling to add more. Score 5.8/10, moderate confidence.
Passes 6/8 gates (clean insider activity, no SEC red flags, news events none recent, earnings proximity 35d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and favorable risk/reward ratio. Suitability: aggressive.
Recent developments
updated 2026-10-12Recent Developments — Oaktree Specialty Lending Corpo
Latest news
- NEWS Oaktree Specialty Lending (OCSL) to Announce Earnings on Wednesday - MarketBeat — MarketBeat neutral
- NEWS Oaktree Specialty Lending Corp (OCSL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey — TradingKey neutral
- NEWS Oaktree Specialty Lending Corp (OCSL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - tradingkey — tradingkey.com neutral
- NEWS Oaktree Specialty Lending Corp (OCSL) Valuation: PE, PB & Fair Value Analysis - TradingKey — TradingKey neutral
- NEWS Oaktree Specialty Lending Corp (OCSL) Valuation: PE, PB & Fair Value Analysis - tradingkey.com — tradingkey.com neutral
Generated 2026-10-13T11:32:15Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
2 floor-breakers·1 ceiling hit
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Momentum below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $11.60, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Leverage penalty (D/E 1.0): -0.5. Chart setup: No clear chart pattern; technical signals are mixed. Maintain position. Not compelling to add more. Target $12.48 (+7.6%), stop $11.15 (−4.0%), A.R:R -1.3:1. Score 5.8/10, moderate confidence.
Take-profit target: $12.48 (-6.2% upside). Target $12.48 (+7.6%), stop $11.15 (−4.0%), A.R:R -1.3:1. Stop-loss: $11.15.
Analyst target reached - limited upside remaining; Leverage penalty (D/E 1.0): -0.5; Negative momentum.
Oaktree Specialty Lending Corpo trades at a P/E of 24.2 (forward 8.5). TrendMatrix value score: 7.3/10. Verdict: Hold.
12 analysts cover OCSL with a consensus score of 2.6/5. Average price target: $13.
What does Oaktree Specialty Lending Corpo do?Oaktree Specialty Lending Corporation is a business development company. The fund specializing in investments in middle...
Oaktree Specialty Lending Corporation is a business development company. The fund specializing in investments in middle market, bridge financing, first and second lien debt financing, unsecured and mezzanine loan, mezzanine debt, senior and junior secured debt, expansions, sponsor-led acquisitions, preferred equity, and management buyouts in small and mid-sized companies. It seeks to invest in education services, business services, retail and consumer, healthcare, manufacturing, food and restaurants, construction and engineering. The firm also seeks investment in media, advertising sectors, software, IT services, pharmaceuticals, biotechnology, real estate management and development, chemicals, machinery, and internet and direct marketing retail sectors. It invests between $5 million to $75 million principally in the form of one-stop, first lien, and second lien debt investments, which may include an equity co-investment component in companies. The firm invest in companies having enterprise value between $20 million and $150 million and EBITDA between $3 million and $50 million. The fund has a hold size of up to $75 million and may underwrite transactions up to $100 million. It primarily invests in North America. The fund seeks to be a lead investor in its portfolio companies.